Nivolumab for Esophageal Carcinoma User Reviews
Brand names: Opdivo
Nivolumab has an average rating of 1.5 out of 10 from a total of 4 reviews for the treatment of Esophageal Carcinoma. 0% of reviewers reported a positive experience, while 100% reported a negative experience.
- Corey
- Taken for 1 to 6 months
- July 20, 2022
Opdivo (nivolumab) "Don’t take this drug it only causes harm. After 4 treatments it fried my thyroid and my adrenal gland’s. I’ve gone through hell for months as they try to adjust my medication. I will have to deal with this for the rest of my life. Your own immune system destroys your organs quickly."
- WWD
- Taken for less than 1 month
- March 3, 2022
"I have Hashimotos Thyroiditis. My body didn’t tolerate the treatment. I had one infusion about 8 weeks ago. The side effects have came in stages. First was the fatigues I wasn’t at a dr appointment, I was trying to rest up.I also had liver pain. My enzymes tripled. The next phase was numbness in my midsection. Every muscle in my abdomen felt as if it were constantly being flexed. This lasted about 6 weeks. The side effects have lessened some what but I have now developed neuropathy. The nerve that seems to be affected is the funny bone nerve in both arms. When laying down it gets worse. While I try to sleep, the nerve gets activated. This is the same feeling as when you hit your funny bone only it lasts a lot longer. The pain is a 10 out of 10. As I already have an autoimmunity, I wondered if this kind of thing might happen. I know people who are having fantastic results from similar treatments. This just wasn’t the right treatment for me."
Frequently asked questions
- VIMAL...
- Taken for 1 to 6 months
- February 4, 2022
"Very harmful drug. I lost my father athe nd oncology Doctors are the worst. They don't accept anything is their fault or manage any complications."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about nivolumab
- Check interactions
- Compare alternatives
- Reviews (123)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Opdivo (nivolumab) "Stay away from this drug if you have esophageal cancer. It won’t work for you but will destroy any “itis” you might be susceptible to. It destroyed my husband’s thyroid and they could never get it back to normal with meds. After 9 infusions, by month 10 his esophageal cancer was back with a vengeance. Optivo does no good for esophageal patients. Just makes things worse."